Trademark: 97928168
Word

Status
Pending
Status Code
730
Status Date
Friday, April 12, 2024
Serial Number
97928168
Mark Type
3
Filing Date
Tuesday, May 9, 2023
Published for Opposition
Tuesday, January 30, 2024

Trademark Owner History
Athira Pharma, Inc. - Owner At Publication

Classifications
5 Prescription pharmaceutical preparations, prescription pharmaceutical compounds in the nature of small molecule chemical compounds, and prescription pharmaceutical compositions for use in the prevention and treatment of neurodegenerative, neurologic, neuropsychiatric and inflammatory disorders such as Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, neuropathy and neuropathic pain, Stroke, Depression, Insomnia, Schizophrenia, Hearing Loss and Rheumatoid Arthritis
42 Pharmaceutical research and development; pharmaceutical drug development services
The mark consists of the a stylized letter "A" consisting of an incomplete star with a circle at the end of three of the points.
Color is not claimed as a feature of the mark.

Trademark Events
May 12, 2023
New Application Entered
Jun 7, 2023
New Application Office Supplied Data Entered
Dec 21, 2023
Assigned To Examiner
Dec 27, 2023
Approved For Pub - Principal Register
Jan 10, 2024
Notification Of Notice Of Publication E-Mailed
Jan 30, 2024
Published For Opposition
Jan 30, 2024
Official Gazette Publication Confirmation E-Mailed
Mar 26, 2024
Noa E-Mailed - Sou Required From Applicant
Apr 12, 2024
Sou Extension 1 Granted
Apr 12, 2024
Sou Teas Extension Received
Apr 12, 2024
Sou Extension 1 Filed
Apr 13, 2024
Notice Of Approval Of Extension Request E-Mailed

Trademark Alertz updated from USPTO on 2030-01-24